CardieX Limited (ASX:CDX)
Australia
· Delayed Price · Currency is AUD 0.0410
+0.0020 (5.13%)
Jun 13, 2025, 11:39 AM AEST
CardieX Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Operating Revenue | 3.07 | 10.91 | 4.6 | 4.07 | 4.98 | 4.29 | Upgrade
|
Other Revenue | 2.65 | 1.91 | 1.09 | 0.67 | 0.53 | 0.49 | Upgrade
|
| Revenue | 5.72 | 12.81 | 5.69 | 4.74 | 5.52 | 4.78 | Upgrade
|
Revenue Growth (YoY) | -59.58% | 125.14% | 20.12% | -14.11% | 15.45% | 0.83% | Upgrade
|
Cost of Revenue | 0.84 | 0.8 | 0.91 | 1.01 | 0.9 | 0.7 | Upgrade
|
Gross Profit | 4.89 | 12.02 | 4.79 | 3.73 | 4.61 | 4.08 | Upgrade
|
Selling, General & Admin | 13.67 | 14.02 | 14.17 | 11.38 | 5.98 | 7.05 | Upgrade
|
Research & Development | 2.51 | 2.49 | 3.91 | 2.38 | 1.75 | 0.63 | Upgrade
|
Other Operating Expenses | - | - | - | - | 0.35 | - | Upgrade
|
Operating Expenses | 17.19 | 16.65 | 20.14 | 15.77 | 9.48 | 7.75 | Upgrade
|
Operating Income | -12.31 | -4.63 | -15.35 | -12.04 | -4.86 | -3.67 | Upgrade
|
Interest Expense | -1.03 | -1.18 | -0.41 | -0.23 | -0.27 | -0.16 | Upgrade
|
Interest & Investment Income | 0.13 | 0.27 | 0.26 | 0.43 | 0.26 | 0.32 | Upgrade
|
Currency Exchange Gain (Loss) | 0.16 | 0.01 | 0.07 | 0.3 | -0.53 | 0.03 | Upgrade
|
Other Non Operating Income (Expenses) | -1.22 | -1.22 | -3.45 | -0.28 | 0.01 | - | Upgrade
|
EBT Excluding Unusual Items | -14.27 | -6.77 | -18.89 | -11.81 | -5.4 | -3.47 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.28 | - | - | - | -0.06 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 0.29 | 0.15 | Upgrade
|
Pretax Income | -14.55 | -6.77 | -18.89 | -11.81 | -5.16 | -3.32 | Upgrade
|
Net Income | -14.55 | -6.77 | -18.89 | -11.81 | -5.16 | -3.32 | Upgrade
|
Net Income to Common | -14.55 | -6.77 | -18.89 | -11.81 | -5.16 | -3.32 | Upgrade
|
Shares Outstanding (Basic) | 277 | 201 | 130 | 103 | 87 | 73 | Upgrade
|
Shares Outstanding (Diluted) | 277 | 201 | 130 | 103 | 87 | 73 | Upgrade
|
Shares Change (YoY) | 95.39% | 54.14% | 26.31% | 18.02% | 20.09% | 19.58% | Upgrade
|
EPS (Basic) | -0.05 | -0.03 | -0.15 | -0.11 | -0.06 | -0.05 | Upgrade
|
EPS (Diluted) | -0.05 | -0.03 | -0.15 | -0.12 | -0.06 | -0.05 | Upgrade
|
Free Cash Flow | -15.22 | -7.84 | -12.05 | -9.57 | -4.04 | -1.87 | Upgrade
|
Free Cash Flow Per Share | -0.06 | -0.04 | -0.09 | -0.09 | -0.05 | -0.03 | Upgrade
|
Gross Margin | 85.37% | 93.77% | 84.08% | 78.75% | 83.66% | 85.39% | Upgrade
|
Operating Margin | -215.03% | -36.16% | -269.73% | -254.02% | -88.13% | -76.75% | Upgrade
|
Profit Margin | -254.16% | -52.80% | -331.86% | -249.25% | -93.54% | -69.49% | Upgrade
|
Free Cash Flow Margin | -265.87% | -61.19% | -211.80% | -202.02% | -73.31% | -39.22% | Upgrade
|
EBITDA | -12.23 | -4.56 | -15.28 | -11.97 | -4.71 | -3.56 | Upgrade
|
EBITDA Margin | -213.75% | -35.59% | -268.46% | -252.71% | -85.47% | -74.49% | Upgrade
|
D&A For EBITDA | 0.07 | 0.07 | 0.07 | 0.06 | 0.15 | 0.11 | Upgrade
|
EBIT | -12.31 | -4.63 | -15.35 | -12.04 | -4.86 | -3.67 | Upgrade
|
EBIT Margin | -215.03% | -36.16% | -269.73% | -254.02% | -88.13% | -76.75% | Upgrade
|
Revenue as Reported | 5.86 | 13.09 | 6.02 | 5.47 | 6.07 | 5.29 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.